Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems)

NCT02515539 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT02515539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02515539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems)
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Withdrawn
Start date
August 31, 2015
Completion date
July 31, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, heart disease, heart valve disease, mitral insufficiency